Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells
1997
Glutathione-Doxorubicin Conjugate and Its Potent Cytotoxicity
publication
Evidence: moderate
Author Information
Author(s): T Asakura, K Ohkawa, N Takahashi, K Takada, T Inoue, S Yokoyama
Primary Institution: Jikei University School of Medicine
Hypothesis
The study investigates the cytotoxic mechanism of a conjugate of doxorubicin and glutathione in rat hepatoma cells.
Conclusion
The glutathione-doxorubicin conjugate exhibits potent cytotoxicity by inhibiting glutathione S-transferase activity.
Supporting Evidence
- GSH-DXR showed non-competitive inhibition of GST activity with an IC50 value of 1.3 µM.
- Substituting amino acids for cysteine in GSH reduced cytotoxicity by two- to fourfold.
- Treatment with tributyltin acetate significantly increased cytotoxicity of GSH-DXR.
Takeaway
A special drug made by combining doxorubicin and glutathione can kill cancer cells better than doxorubicin alone.
Methodology
The study used rat hepatoma cell lines to compare the cytotoxic effects of doxorubicin and its conjugate with glutathione.
Participant Demographics
Rat hepatoma cells (AH66P and AH66DR).
Want to read the original?
Access the complete publication on the publisher's website